Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Corvus Pharmaceuticals (CRVS) Q4 2023 Earnings
CRVS
+0.75%
19
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.17
-0.15
-0.14
-0.12
Details
Expected EPS
-0.12
Actual EPS
-0.14
Surprise EPS
-0.02
Surprise Percent
+16.67%
Description
Corvus Pharmaceuticals (CRVS) has reported earnings of -0.14 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login